Japanese Institute Fails to Reproduce Results of Controversial Stem-Cell … – Wall Street Journal
Wall Street Journal |
Japanese Institute Fails to Reproduce Results of Controversial Stem–Cell …
Wall Street Journal TOKYO—Japan’s Riken research institute said Friday that efforts to reproduce results of what was once billed as a groundbreaking method of creating stem cells have failed, likely bringing to a close a scandal that rocked the scientific community. Still no stem cells via easy ‘STAP’ pathNature.com Disgraced Japan researcher fails to replicate ‘game changing’ stem cell resultsYahoo News Discredited Japanese researcher resigns after lab fails to replicate stem cell …Minneapolis Star Tribune The Straits Times –South China Morning Post (subscription) –Asahi Shimbun all 22 news articles » |
Wall Street Journal |
Japanese Institute Fails to Reproduce Results of Controversial Stem–Cell …
Wall Street Journal TOKYO—Japan’s Riken research institute said Friday that efforts to reproduce results of what was once billed as a groundbreaking method of creating stem cells have failed, likely bringing to a close a scandal that rocked the scientific community. Still no stem cells via easy ‘STAP’ pathNature.com Disgraced Japan researcher fails to replicate ‘game changing’ stem cell resultsYahoo News Discredited Japanese researcher resigns after lab fails to replicate stem cell …Minneapolis Star Tribune The Straits Times –South China Morning Post (subscription) –Asahi Shimbun all 22 news articles » |
U-T San Diego |
Europe boosts stem cell patent rights
U-T San Diego Stem cells produced by Carlsbad’s International Stem Cell Corp. can be patented, a European court ruled Thursday. The decision allows the biotech company to get patents for its stem cells made from unfertilized, or parthenogenetic, human egg cells. EU’s top court opens door to some stem cell patentsReuters EU stem cell ruling paves the way to stem cell patentsDeutsche Welle judgment opens way for stem–cell patentsFinancial Times Businessweek –CNNMoney all 49 news articles » |
U-T San Diego |
Europe boosts stem cell patent rights
U-T San Diego Stem cells produced by Carlsbad’s International Stem Cell Corp. can be patented, a European court ruled Thursday. The decision allows the biotech company to get patents for its stem cells made from unfertilized, or parthenogenetic, human egg cells. EU stem cell ruling paves the way to stem cell patentsDeutsche Welle EU’s top court opens door to some stem cell patentsReuters Stem–Cell Use Gets EU Boost as Court Seen Skipping Sci-FiBusinessweek Financial Times –CNNMoney all 58 news articles » |
|
Year in Review: Advances in Stem Cell Research
Wall Street Journal 2014 was a year of high-profile advances and one big scandal in the field of stem cell science. WSJ’s Gautam Naik reports. Transcript +. This transcript has been automatically generated and may not be 100% accurate. two thousand fourteen was the year … |
|
Year in Review: Advances in Stem Cell Research
Wall Street Journal 2014 was a year of high-profile advances and one big scandal in the field of stem cell science. WSJ’s Gautam Naik reports. Transcript +. This transcript has been automatically generated and may not be 100% accurate. two thousand fourteen was the year … |